ID: h-gap-2f2e5b80-m1
Hypothesis
TLR4 priming is the actionable driver in: How does gut microbiome dysbiosis contribute to neuroinflammation and neurodegeneration th
The gap can be tested by treating TLR4 priming as an upstream driver rather than a passive correlate.
EvidencePending (0%)📖 6 cit🗣 2 debates✓ 6 support✗ 1 oppose
✓ All Quality Gates Passed
🧪 Overview
The gap can be tested by treating TLR4 priming as an upstream driver rather than a passive correlate. If true, perturbing butyrate-restoring consortia should shift fecal butyrate before downstream neurodegeneration markers change.
🧬 Mechanism
🧬 Curated Mechanism Pathway
Curated pathway from expert analysis
flowchart TD
A["Gut Dysbiosis<br/>SCFA-Producing Bacteria Loss"]
B["Intestinal Permeability<br/>Leaky Gut Endotoxemia"]
C["LPS Translocation<br/>Portal and Systemic Circulation"]
D["TLR4 Activation<br/>MD-2 Coreceptor Complex"]
E["MyD88 Signaling<br/>NF-kappaB and MAPK Cascade"]
F["Peripheral Cytokine Storm<br/>IL-1beta and TNF Secretion"]
G["Microglial Priming<br/>Brain Resident Immune Activation"]
H["Neurodegeneration<br/>Synapse Loss and Tau Pathology"]
A --> B
B --> C
C --> D
D --> E
E --> F
F --> G
G --> H
style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
style D fill:#7b1fa2,stroke:#ce93d8,color:#ce93d8
style G fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
style H fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a⚖️ Evidence
⚖️ Evidence Matrix5 supports1 contradicts
Supports
TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling.
Supports
The role of Toll-like receptors and neuroinflammation in Parkinson's disease.
Supports
Gastrodin regulates the TLR4/TRAF6/NF-κB pathway to reduce neuroinflammation and microglial activation in an AD model.
Supports
α-synuclein suppresses microglial autophagy and promotes neurodegeneration in a mouse model of Parkinson's disease.
Contradicts
causal direction requires longitudinal perturbation
skeptic_round
📖 Linked Papers (15)Export BibTeX ↗
Iron and the Intestinal Microbiome.
Adv Exp Med Biol (2025) · PubMed:40603801 ↗
No figures
Oral Microbiome: A Review of Its Impact on Oral and Systemic Health.
Microorganisms (2024) · PubMed:39338471 ↗
No figures
Gastrodin regulates the TLR4/TRAF6/NF-κB pathway to reduce neuroinflammation and microglial activation in an AD model.
Phytomedicine : international journal of phytotherapy and phytopharmacology (2024) · PubMed:38552431 ↗
No figures
Gastrodin regulates the TLR4/TRAF6/NF-κB pathway to reduce neuroinflammation and microglial activation in an AD model.
Phytomedicine : international journal of phytotherapy and phytopharmacology (2024) · PubMed:38552431 ↗
No figures
The role of the microbiota in glaucoma.
Molecular aspects of medicine (2023) · PubMed:37866106 ↗
No figures
The role of the microbiota in glaucoma.
Molecular aspects of medicine (2023) · PubMed:37866106 ↗
No figures
The role of Toll-like receptors and neuroinflammation in Parkinson's disease.
Journal of neuroinflammation (2022) · PubMed:35668422 ↗
No figures
The role of Toll-like receptors and neuroinflammation in Parkinson's disease.
Journal of neuroinflammation (2022) · PubMed:35668422 ↗
No figures
Oral microbiome and pregnancy: A bidirectional relationship.
J Reprod Immunol (2021) · PubMed:33676065 ↗
No figures
TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling.
Cellular and molecular life sciences : CMLS (2021) · PubMed:33057840 ↗
No figures
🏥 Translation
🧬 3D Protein Structure — TLR4
🧠 GTEx v10 Brain ExpressionJSON
Median TPM across 13 brain regions for TLR4 priming from GTEx v10.
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for TLR4 priming.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↔
Stable
7d Momentum
▼ 0.6%
Volatility
High
0.1444
Events (7d)
3
Price History
▼21.9%💾 Resource Usage
No resource usage or linked notebooks recorded for this hypothesis yet.
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF TLR4 priming is the gut-dysbiosis driver of neuroinflammation, THEN fecal microbiota transfer from dysbiotic donors will raise microglial TLR4/NF-kB activation by >=30% within 6 weeks in germ-free | Recipient mice show >=30% increase in microglial TLR4/NF-kB activation markers versus healthy-donor FMT recipients. | — no observation — | pending | 0.65 |
| IF TLR4 is actionable upstream, THEN pharmacologic or genetic TLR4 inhibition will prevent at least 50% of dysbiosis-induced IL-1B/TNF microglial upregulation within 8 weeks. | TLR4 inhibition reduces dysbiosis-induced microglial IL-1B/TNF signal by >=50% versus untreated dysbiotic controls. | — no observation — | pending | 0.62 |
🔮 Falsifiable Predictions (2)
pendingconf 65%
IF TLR4 priming is the gut-dysbiosis driver of neuroinflammation, THEN fecal microbiota transfer from dysbiotic donors will raise microglial TLR4/NF-kB activation by >=30% within 6 weeks in germ-free mice.
Predicted outcome: Recipient mice show >=30% increase in microglial TLR4/NF-kB activation markers versus healthy-donor FMT recipients.
Falsification: Activation increase is <10% or is unchanged by TLR4 blockade.
pendingconf 62%
IF TLR4 is actionable upstream, THEN pharmacologic or genetic TLR4 inhibition will prevent at least 50% of dysbiosis-induced IL-1B/TNF microglial upregulation within 8 weeks.
Predicted outcome: TLR4 inhibition reduces dysbiosis-induced microglial IL-1B/TNF signal by >=50% versus untreated dysbiotic controls.
Falsification: TLR4 inhibition reduces cytokine signal by <20% despite target engagement.
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesis
| source | v1_phase_c_backfill |
| origin_type | debate_synthesis |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.